OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Moclobemide as add-on therapy to agomelatine in a patient with treatment-resistant major depressive disorder: a psychopharmacological case
Matej Štuhec, Róbert Oravecz
Wiener klinische Wochenschrift (2015) Vol. 128, Iss. 7-8, pp. 295-298
Closed Access | Times Cited: 7
Matej Štuhec, Róbert Oravecz
Wiener klinische Wochenschrift (2015) Vol. 128, Iss. 7-8, pp. 295-298
Closed Access | Times Cited: 7
Showing 7 citing articles:
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial
Yongqin Ju, Wenwen Ou, Hao Chen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Yongqin Ju, Wenwen Ou, Hao Chen, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Major Depressive Disorder and Kappa Opioid Receptor Antagonists.
Wei Li, Huijiao Sun, Hao Chen, et al.
PubMed (2016) Vol. 1, Iss. 2, pp. 4-16
Closed Access | Times Cited: 34
Wei Li, Huijiao Sun, Hao Chen, et al.
PubMed (2016) Vol. 1, Iss. 2, pp. 4-16
Closed Access | Times Cited: 34
What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?
Petr Potměšil
Therapeutic Advances in Psychopharmacology (2019) Vol. 9
Open Access | Times Cited: 20
Petr Potměšil
Therapeutic Advances in Psychopharmacology (2019) Vol. 9
Open Access | Times Cited: 20
Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, et al.
Brazilian Journal of Psychiatry (2020) Vol. 42, Iss. 3, pp. 317-321
Open Access | Times Cited: 18
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, et al.
Brazilian Journal of Psychiatry (2020) Vol. 42, Iss. 3, pp. 317-321
Open Access | Times Cited: 18
Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
Mandeep Kaur, Marsal Sanches
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 181-196
Open Access | Times Cited: 8
Mandeep Kaur, Marsal Sanches
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 181-196
Open Access | Times Cited: 8
Major Depressive Disorder and Kappa Opioid Receptor
Wei Li, Sun Huijiao, Chen Hao, et al.
Translational Perioperative and Pain Medicine (2016) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Wei Li, Sun Huijiao, Chen Hao, et al.
Translational Perioperative and Pain Medicine (2016) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia
Maxim A. Novitsky, Alexandra Sousa, Azat R. Asadullin, et al.
Personalized Psychiatry and Neurology (2021) Vol. 1, Iss. 2, pp. 21-45
Open Access | Times Cited: 3
Maxim A. Novitsky, Alexandra Sousa, Azat R. Asadullin, et al.
Personalized Psychiatry and Neurology (2021) Vol. 1, Iss. 2, pp. 21-45
Open Access | Times Cited: 3
